We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
+12.77%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.58B
AUM Growth
-$4.87M
Cap. Flow
-$87.2M
Cap. Flow %
-3.38%
Top 10 Hldgs %
22.3%
Holding
280
New
32
Increased
93
Reduced
111
Closed
26

Top Buys

Rank Stock Value
1
TMDX icon
Transmedics
TMDX
+$20.6M
2
BOOT icon
Boot Barn
BOOT
+$19.4M
3
TBBK icon
The Bancorp
TBBK
+$18.4M
4
SITM icon
SiTime
SITM
+$17.7M
5
ALGT icon
Allegiant Air
ALGT
+$17.2M

Sector Composition

Rank Sector Weight
1 Technology 26.14%
2 Healthcare 24.06%
3 Industrials 19.5%
4 Financials 12.26%
5 Consumer Discretionary 6.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
YOU icon
276
Clear Secure
YOU
$5.35B
-292,257
Closed -$9.69M
PAL
277
Proficient Auto Logistics
PAL
$189M
-73,699
Closed -$1.05M
BIOA
278
BioAge Labs
BIOA
$981M
-281,317
Closed -$5.85M
CDMO
279
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
-1,448,916
Closed -$16.5M
LBPH
280
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
-683,642
Closed -$22.8M

Similar funds

Emerald Advisers's Q4 2024 Portfolio in Review

As of Q4 2024, Emerald Advisers held 280 positions worth $2.58B, down 0.19% from $2.59B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Emerald Advisers withdrew a net $87.2M in Q4 2024, closing 26 positions and reducing 111 holdings. Its most notable exit was Longboard Pharmaceuticals, Inc. Common Stock, an estimated $22.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Emerald Advisers opened a new position in Boot Barn worth $20M.

  • Emerald Advisers's largest Q4 2024 buy was Boot Barn: 131,637 shares worth $20M.
  • Emerald Advisers added most to Transmedics in Q4 2024, an estimated $20.6M increase.
  • Emerald Advisers's biggest Q4 2024 reduction was Carpenter Technology, cutting an estimated $26.4M.
  • Emerald Advisers fully exited Longboard Pharmaceuticals, Inc. Common Stock in Q4 2024, selling an estimated $22.8M.
  • Emerald Advisers's ten largest holdings make up 22% of its $2.58B portfolio in Q4 2024.
  • Emerald Advisers opened 32 new positions and closed 26 in Q4 2024.
  • Emerald Advisers's portfolio value fell 0.19% quarter-over-quarter to $2.58B.

Based on Emerald Advisers's 13F filing for Q4 2024, filed 11 Feb 2025.